Psychotropic drug use among older people in general practice: discrepancies between opinion and practice
- PMID: 20353661
- PMCID: PMC2845506
- DOI: 10.3399/bjgp10X483922
Psychotropic drug use among older people in general practice: discrepancies between opinion and practice
Abstract
Background: The use of psychotropic drugs has increased over recent years in France. GPs are the first prescribers, especially for older patients.
Aim: To analyse discrepancies between GPs' opinions and practice when prescribing psychotropic drugs to older patients.
Setting: Postal surveys sent to GPs all over mainland France.
Design of study: Cross-sectional postal study.
Method: A questionnaire collected data on characteristics of GPs' practices, their opinions about psychotropic drug consumption in older people, and a full description of their last older patient receiving a psychotropic drug and seen last by the GP on that particular day.
Results: A total of 350 participating GPs saw 2498 patients aged > or =65 years. Among these patients, the prevalence of psychotropic use was 32.1% (803/2498) for anxiolytics/hypnotics, and 17.5% for antidepressants (438/2498). A total of 91% of GPs agreed that it was possible to reduce or stop psychotropic drugs for these patients. Characteristics of 339 patients taking psychotropic drug were reported: 85.8% (291/339) received at least one anxiolytic/hypnotic and 56.9% (193/339) received at least one antidepressant; there were prescribed for more than 1 year in 68.4% (199/291) and 43.5% (84/193) of the cases respectively. GPs stated that it was possible to reduce or stop anxiolytic/hypnotic drugs for only 27% (79/291) of these patients. Barriers to doing this were patients' refusal (79%), and the absence of any local offer of psychotherapy (73%) or alternative therapy (70%).
Conclusion: A mismatch exists between GPs' intent (91%) and practice (27%) regarding reduction of psychotropic prescription in individuals aged > or =65 years. The barriers encountered should be examined further to help physicians improve management of psychotropic prescription.
Figures
References
-
- Gasquet I, Nègre-Pagès L, Fourrier A, et al. Psychotropic drug use and mental psychiatric disorders in France: results of the general population ESEMeD/MHEDEA 2000 epidemiological study. Encephale. 2005;31:195–206. - PubMed
-
- Alonso J, Angermeyer MC, Bernert S, et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004;(420):55–64. - PubMed
-
- Ohayon M, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy and United Kingdom. J Clin Psychiatry. 2002;63(9):817–825. - PubMed
-
- Lecadet J, Vidal P, Baris B, et al. Médicaments psychotropes: consommation et pratiques de prescription en France métropolitaine [in French] Rev Med Ass Maladie. 2003;34(1):75–84.
-
- Briot M. Assemblée Nationale No 3187. Rapport sur le bon usage des médicaments psychotropes. [Adequate use of psychotropic treatments, a report]. http://www.assemblee-nationale.fr/12/rap-off/i3187.asp (accessed 6 Nov 2009)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials